HERON THERAPEUTICS, INC. /DE/ (HRTX) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Heron Therapeutics, Inc. /De/ Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$3.16 M, a 90.4% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$81 M, a 46.4% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2023 was -$111 M, a 39.3% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2022 was -$182 M, a 17.5% increase from 2021.
  • Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2021 was -$221 M, a 2.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$81 M -$3.16 M +$29.6 M +90.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$111 M -$10.7 M +$9.15 M +46% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$120 M -$25 M +$16.9 M +40.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$137 M -$42.1 M +$14.3 M +25.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-14
Q1 2023 -$151 M -$32.8 M +$31.1 M +48.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$182 M -$19.9 M +$34.8 M +63.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$217 M -$41.9 M +$10.5 M +20% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$227 M -$56.4 M +$4.66 M +7.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$232 M -$63.9 M -$11.3 M -21.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$221 M -$54.6 M +$7.64 M +12.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$228 M -$52.4 M +$5.82 M +10% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$234 M -$61 M -$5.83 M -10.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$228 M -$52.6 M -$1.04 M -2.01% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$227 M -$62.3 M -$4.36 M -7.53% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$223 M -$58.2 M -$24.6 M -73.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$198 M -$55.2 M -$4.97 M -9.89% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 -$193 M -$51.6 M +$11.4 M +18.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 -$205 M -$57.9 M -$8.36 M -16.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$196 M -$33.6 M +$4.75 M +12.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$201 M -$50.2 M -$11.6 M -29.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$190 M -$63 M -$10.7 M -20.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$179 M -$49.6 M +$12.9 M +20.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$192 M -$38.3 M +$3.52 M +8.41% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$195 M -$38.7 M +$4.13 M +9.65% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$199 M -$52.3 M -$1.94 M -3.85% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$197 M -$62.5 M -$14.5 M -30.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-22
Q3 2017 -$183 M -$41.9 M +$6.64 M +13.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-22
Q2 2017 -$190 M -$42.8 M +$427 K +0.99% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-22
Q1 2017 -$190 M -$50.3 M -$16.9 M -50.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-22
Q4 2016 -$173 M -$48 M -$16.7 M -53.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$156 M -$48.5 M -$25.8 M -114% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 -$131 M -$43.2 M -$20.1 M -87.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 -$110 M -$33.4 M -$12.9 M -62.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 -$97.6 M -$31.2 M -$10.6 M -51.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$87 M -$22.7 M -$3.48 M -18.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$83.5 M -$23.1 M -$4.1 M -21.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$79.4 M -$20.6 M -$3.03 M -17.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 -$76.4 M -$20.6 M -$6.58 M -46.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 -$69.8 M -$19.2 M -$6.32 M -49.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 -$63.5 M -$19 M -$3.6 M -23.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 -$59.9 M -$17.5 M -$4.59 M -35.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
Q4 2013 -$55.3 M -$14 M -$6.31 M -81.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$49 M -$12.9 M -$6.75 M -110% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$42.2 M -$15.4 M -$10.8 M -237% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$31.4 M -$13 M $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$31.4 M -$7.74 M -$3.48 M -81.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$27.9 M -$6.12 M -$1.92 M -45.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-07
Q2 2012 -$26 M -$4.57 M -$2.64 M -136% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-07
Q1 2012 -$23.3 M -$13 M -$11.5 M -813% Jan 1, 2012 Mar 31, 2012 10-K 2015-03-13
Q4 2011 -$11.8 M -$4.26 M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 -$4.2 M -$2.53 M -151% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 -$1.93 M +$1.65 M +46.1% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 -$1.42 M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q3 2010 -$1.67 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$3.58 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.